Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Feb;105(2):490–494. doi: 10.1111/j.1476-5381.1992.tb14281.x

The actions of endothelins-1 and -3 on the vascular and capsular smooth muscle of the isolated blood perfused spleen of the dog.

P G Withrington 1, N Ansari 1, R Croxton 1, G de Nucci 1, J R Vane 1
PMCID: PMC1908655  PMID: 1559137

Abstract

1. Endothelin-1 (ET-1), endothelin-3 (ET-3) and noradrenaline (NA) were administered as intra-arterial bolus injections into the isolated, blood-perfused spleen of the dog to assess agonist properties and relative molar potencies on the vascular and capsular smooth muscle. 2. An initial small vasodilatation was observed occasionally at low doses (1.0-10 pmol) of ET-1. 3. ET-1, ET-3 and NA all caused graded increases in splenic arterial vascular resistance. The molar ED50 for the splenic vasoconstrictor response to ET-1 was significantly less (P less than 0.001) than that to ET-3; both peptides were significantly more potent as vasoconstrictor agents than NA. The maximum increase in splenic arterial vascular resistance was not significantly different for either ET-1, ET-3 or NA. 4. The time course of the splenic vasoconstrictor response to ET-1 was significantly (P less than 0.01) longer than that to equieffective doses of ET-3 or NA. 5. The splenic vasoconstrictor responses to ET-1 and ET-3 were accompanied by reductions in spleen volume. The rank order of molar potency in causing splenic capsular contraction was ET-1 greater than ET-3 greater than NA. The maximum reduction in splenic volume was significantly greater for NA than for either ET-1 or ET-3. The two peptides (ET-1, ET-3) were equiefficacious in contracting splenic capsular smooth muscle. 6. The high molar potency of ET-1 as a splenic arterial vasoconstrictor, over 1,700 times more potent than NA, suggests that it may play an important local role in the control of splenic haemodynamics.

Full text

PDF
490

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corder R., Lowry P. J., Withrington P. G. The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog. Br J Pharmacol. 1987 Apr;90(4):785–790. doi: 10.1111/j.1476-5381.1987.tb11232.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Corder R., Withrington P. G. A comparison of the differential effects of vasoactive intestinal peptide and peptide histidine isoleucine on the vascular and capsular smooth muscle of the dog spleen. Br J Pharmacol. 1988 Oct;95(2):664–670. doi: 10.1111/j.1476-5381.1988.tb11689.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davies B. N., Gamble J., Withrington P. G. Frequency-dependent differences in the responses of the capsular and vascular smooth muscle of the spleen of the dog to sympathetic nerve stimulation. J Physiol. 1973 Jan;228(1):13–25. doi: 10.1113/jphysiol.1973.sp010069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davies B. N., Robinson B. H., Withrington P. G. The effects of graded doses of phenoxybenzamine on the vascular and capsular responses of the isolated, blood-perfused dogs spleen to sympathetic nerve stimulation and catecholamines. Arch Int Pharmacodyn Ther. 1969 Jul;180(1):143–154. [PubMed] [Google Scholar]
  5. Eglen R. M., Michel A. D., Sharif N. A., Swank S. R., Whiting R. L. The pharmacological properties of the peptide, endothelin. Br J Pharmacol. 1989 Aug;97(4):1297–1307. doi: 10.1111/j.1476-5381.1989.tb12592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Franco-Cereceda A., Henke H., Lundberg J. M., Petermann J. B., Hökfelt T., Fischer J. A. Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin. Peptides. 1987 Mar-Apr;8(2):399–410. doi: 10.1016/0196-9781(87)90117-3. [DOI] [PubMed] [Google Scholar]
  7. Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats. Br J Pharmacol. 1990 Jan;99(1):107–112. doi: 10.1111/j.1476-5381.1990.tb14662.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863–2867. doi: 10.1073/pnas.86.8.2863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Koseki C., Imai M., Hirata Y., Yanagisawa M., Masaki T. Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am J Physiol. 1989 Apr;256(4 Pt 2):R858–R866. doi: 10.1152/ajpregu.1989.256.4.R858. [DOI] [PubMed] [Google Scholar]
  10. Lundberg J. M., Anggård A., Pernow J., Hökfelt T. Neuropeptide Y-, substance P- and VIP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control. Cell Tissue Res. 1985;239(1):9–18. doi: 10.1007/BF00214896. [DOI] [PubMed] [Google Scholar]
  11. Lundberg J. M., Rudehill A., Sollevi A., Hamberger B. Evidence for co-transmitter role of neuropeptide Y in the pig spleen. Br J Pharmacol. 1989 Mar;96(3):675–687. doi: 10.1111/j.1476-5381.1989.tb11868.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Minkes R. K., Kadowitz P. J. Differential effects of rat endothelin on regional blood flow in the cat. Eur J Pharmacol. 1989 Jun 8;165(1):161–164. doi: 10.1016/0014-2999(89)90784-x. [DOI] [PubMed] [Google Scholar]
  13. Power R. F., Wharton J., Zhao Y., Bloom S. R., Polak J. M. Autoradiographic localization of endothelin-1 binding sites in the cardiovascular and respiratory systems. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S50–S74. doi: 10.1097/00005344-198900135-00013. [DOI] [PubMed] [Google Scholar]
  14. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990 Dec 20;348(6303):732–735. doi: 10.1038/348732a0. [DOI] [PubMed] [Google Scholar]
  15. Walder C. E., Thomas G. R., Thiemermann C., Vane J. R. The hemodynamic effects of endothelin-1 in the pithed rat. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S93–S102. doi: 10.1097/00005344-198900135-00023. [DOI] [PubMed] [Google Scholar]
  16. Warner T. D., Mitchell J. A., de Nucci G., Vane J. R. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S85–S102. doi: 10.1097/00005344-198900135-00021. [DOI] [PubMed] [Google Scholar]
  17. Whittle B. J., Lopez-Belmonte J., Rees D. D. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol. 1989 Oct;98(2):646–652. doi: 10.1111/j.1476-5381.1989.tb12639.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Withrington P. G. The relaxant properties of human calcitonin gene-related peptide on vascular and extravascular capsular) smooth muscle of the isolated blood-perfused spleen of the anaesthetized dog. Br J Pharmacol. 1989 Apr;96(4):823–828. doi: 10.1111/j.1476-5381.1989.tb11890.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Withrington P. G., de Nucci G., Vane J. R. Endothelin-1 causes vasoconstriction and vasodilation in the blood perfused liver of the dog. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S209–S210. doi: 10.1097/00005344-198900135-00060. [DOI] [PubMed] [Google Scholar]
  20. Yanagisawa M., Inoue A., Ishikawa T., Kasuya Y., Kimura S., Kumagaye S., Nakajima K., Watanabe T. X., Sakakibara S., Goto K. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6964–6967. doi: 10.1073/pnas.85.18.6964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. de Nucci G., Thomas R., D'Orleans-Juste P., Antunes E., Walder C., Warner T. D., Vane J. R. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9797–9800. doi: 10.1073/pnas.85.24.9797. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES